How did the introduction of managed care for the uninsured in Iowa affect the use of substance abuse services? by Ettner, Susan L et al.
UCLA
UCLA Previously Published Works
Title
How did the introduction of managed care for the uninsured in Iowa 
affect the use of substance abuse services?
Permalink
https://escholarship.org/uc/item/60g262cs
Journal
The journal of behavioral health services & research, 30(1)
ISSN
1094-3412
Authors
Ettner, Susan L
Argeriou, Milton
McCarty, Dennis
et al.
Publication Date
2003
DOI
10.1007/BF02287811
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
How Did the Introduction of Managed Care 
for the Uninsured in Iowa Affect the Use 
of Substance Abuse Services? 
Susan L. Ettner, PhD 
Milton Argeriou, PhD 
Dennis McCarty, PhD 
Joan Dilonardo, PhD 
Hui Liu 
Abstract 
Concerns about access under managed care have been raised for vulnerable populations uch 
as publicly funded patients with substance abuse problems. To estimate the effects of the Iowa 
Managed Substance Abuse Care Plan (IMSACP) on substance abuse service use by publicly funded 
patients, service use before and after IMSACP was compared; adjustments were made for changes 
in population sociodemographic and clinical characteristics. Between fiscal years 1994 and 1997, 
patient case mix was marked by a higher burden of illness and the use of inpatient, residential non- 
detox, outpatient counseling, and assessment services declined, while use of intensive outpatient and 
residential detox services increased. Findings were similar among women, children, and homeless 
persons. Thus, care moved away from high-cost inpatient settings to less costly venues. Without 
knowing the impact on treatment outcomes, these changes cannot be interpreted as improved provider 
efficiency versus simply cost containment and profit maximization. 
Introduction 
Managed care, or "programs designed to control  access to care, types of care delivered, or the 
amount/costs  of care," has changed the organizat ion and f inancing of  health care and has restructured 
private sector delivery of  substance abuse and menta l  health services. 1~p57~ However,  the appl ication 
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of managed care principles to the chronic relapsing conditions of substance abuse and mental illness 
has generated concerns about he goodness-of-fit of the model to these diseases 2-8 and the heightened 
potential for adverse/biased selection to occur. 9' 10 Due to social complications (eg, homelessness, 
pregnancy, and court orders), stigma, and denial, alcohol- and drug-dependent i dividuals may fail 
to seek care, and health care providers may fail to diagnose and refer individuals in need of alcohol 
and drug treatment. 3 Thus managed care must make special efforts to promote identification and 
facilitate access to care for this vulnerable subpopulation. 
Public sector purchasers also have been turning to managed behavioral health care as a strategy 
to control costs, enhance the effectiveness of services, improve the quality of care, and integrate 
substance abuse and mental health services. However, state and federal officials charged with de- 
veloping managed care programs currently lack a body of systematic evaluations that link managed 
care attributes to changes in state substance and mental health treatment systems, or that measure 
the impact of these changes on system functions, resources, and results. 
The application of managed care is especially challenging in publicly funded systems of alcohol 
and drug dependence intervention and treatment services. 11,12 The men, women, and children served 
in public systems typically have greater levels of impairment due to alcohol and drug dependence 
and a greater range of clinical and social needs than observed among populations insured through 
employer-sponsored health plans, t3'14 Compared with employed individuals, Medicaid recipients 
and uninsured individuals tend to have longer histories of use and abuse, may be more likely to abuse 
multiple substances, report more health and social debilitation, and are more likely to be involved 
with the criminal justice system. 14 
As described in the earlier overview, the goal of the multisite study was to acquire information that 
would inform the development and implementation f managed care programs for publicly funded 
substance abuse treatment services. 15 The current study reports on the results from an investigation of
the Iowa Managed Substance Abuse Care Plan (IMSACP) described in the overview. The objective of 
this particular evaluation was to describe and assess the impact of the change in payment structure on 
the treatment service patterns of non-Medicaid substance abuse clients in Iowa. More specifically, the 
following two research questions were investigated: (l) Did the characteristics of the client population 
served change following the introduction of IMSACP? and (2) Holding client characteristics constant, 
did the length of treatment, type of substance abuse services, intensity, or number of services change 
following the introduction of IMSACP? These issues were addressed through analysis of pre- and 
post-IMSACP data from the Iowa Department ofPublic Health's Substance Abuse R porting System 
(SARS). 
Researchers atthe Consortium for Substance Abuse Research previously conducted two studies 
to evaluate the impact of IMSACP on non-Medicaid clients. 16'17 Both studies used SARS data and 
neither study found much impact of managed care on the accessibility and measurable outcomes 
of the system delivering substance abuse treatment to state-funded clients. However, both studies 
were limited in their interpretability. The first study was based on only 10 months of post-IMSACP 
data and ended up including Medicaid beneficiaries in the sample along with the non-Medicaid 
clientsJ 6 The second study was intended to describe the impact of managed care on clients receiv- 
ing services in all treatment agencies approved for public funding, not just those paid by the Iowa 
Department of Public Health. 17 However, because the SARS system did not include a number of 
the post-managed care providers in the pre-managed care period, the failure to exclude the new 
providers from analysis is likely to have led to a bias in comparing treatment patterns before and 
after the introduction of IMSACP. Furthermore, as with the earlier study, analyses were based on 
the first year of implementation ly, so they were subject o early stage fluctuations that often 
attend operational changes. The current study seeks to address these limitations by using compa- 
rable pre- and post-managed care data and analyzing files from fiscal years (FYs) 1994 through 
1998. 
Introduction of Managed Care ETTNER et al. 27 
Methods 
SARS database 
The data set used for the study was the Iowa Department of Public Health's SARS. SARS in- 
cludes admission, service, follow-up, and discharge forms. Admission forms contain a variety of 
sociodemographic and drinking profile data. They are completed for new clients and for previously 
serviced clients who have had a break of 30 days or more in treatment. Only one admission form 
may exist for a client at any one point in time. Discharge forms must be completed for previously 
serviced clients before a new admission form can be completed. Service forms are completed each 
month for services provided on or before the last day of the month. Follow-up forms are completed 
for selected portions of the treatment population. Data from the SARS client admission forms and 
service forms were used in this evaluation. These data were retrieved for the period beginning July 
1993 to June 1998 (FYs 1994-1998). Due to the introduction f new data forms at the beginning 
of FY 1996, it was necessary to carefully map variables from the earlier and later years to ensure 
comparability over time. 
Timeline and episode creation 
To allow sufficient follow-up time for each observation, only patients entering treatment during 
FY 1994 (prior to IMSACP) and those entering treatment during FY 1997 (after IMSACP had 
been fully implemented) were compared. For example, patients who were admitted to treatment 
immediately preceding the end of the data in FY 1998 were not included. Two months of data at 
the beginning of FY 1996 were missing as the result of the transition to different data forms, so 
episodes beginning close to the missing data period also would have been truncated. Analysis was 
limited to episodes beginning in FY 1994 and FY 1997 so that there would be at least 1 year of 
potential follow-up for each episode and to avoid comparing patients who began treatment during 
the transition to IMSACP. Early managed care results, such as those previously published, might not 
generalize to the "steady-state" after IMSACP had been fully implemented. 
Episodes were created by aggregating allservice records for the rolling 12-month period beginning 
with the patient's first month of services during the given year (FY 1994 or FY 1997). The service 
use data were linked to admissions records from the first month of the service data. That is, if the 
patient first received services in September 1993, then the patient's ervice data would be linked 
to admissions record data for September 1993. In a few cases, multiple admissions records were 
identified for the same month, so data were taken from the first admissions record. 
As an alternative to "fixed-length" episodes, "variable-length" episodes were constructed by ag- 
gregating service records from adjacent months only, starting with the first month of service during 
the given year. A new episode was defined by either a break in service or the receipt of detox 
services (which generally suggests a relapse and a new beginning to treatment). An advantage of 
variable-length episodes is that they allow an examination of changes in the duration and intensity 
of treatment. Figure 1 illustrates the difference between the fixed- and variable-length episodes. As 
an example of how they differ, suppose a patient received outpatient services during September, 
October, and November 1993 and again during January and February 1994. Using the fixed-length 
episode definition, all those services (all services received between September 1993 and August 
1994) would have been added up for a single observation. In contrast, the same pattern of ser- 
vices would be treated as two separate variable-length episodes. The first episode would include 
only the services received from September through November, since there was a break in treat- 
ment between November and January. The services received uring January and February would 
constitute a second episode. Furthermore, if the patient also had detox services during the month 
of October, then this pattern would actually have been included in the database as three separate 
episodes, the first a 1-month episode during September 1993, the second a 2-month episode from 
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F igure  1 
Difference between (a) fixed- and (b) variable-length episodes in the transition to the Iowa 
Managed Substance Abuse Care Plan (IMSACP). 
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October through November 1993, and the third a 2-month episode from January through February 
1994. 
Sample exclusions 
As the intent of the SARS analyses was to examine the impact of IMSACP on the Department of
Public Health-funded treatment service system and on non-Medicaid service recipients, the SARS 
data were screened to include only those providers who had participated in SARS and who were 
Iowa Department of Public Health (IDPH)-funded for the period of the study (ie, FYs 1994-1998). 
Medicaid patients were not included in the analysis, because Medicaid providers were not required 
to submit data to the SARS for these patients prior to the introduction of IMSACP, so no "before and 
after" comparison could be made. Medicaid beneficiaries, accounting for about 16% of the episodes, 
were identified using linked Medicaid eligibility files and excluded. Medicaid coverage could not 
be determined for patients missing the last four digits of their Social Security number, representing 
half of 1% of the patients in the SARS database, so these observations also were dropped. 
Service use data could not be linked to corresponding admissions data for about 15% of the 
episodes, so those observations were dropped. Of those observations, about 16% (or about 2% of 
the total sample) were "concerned" clients (ie, persons receiving services as a result of having a 
family member or friend who abuses ubstances). Providers were not required to fill out most of the 
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admissions file information for concerned clients. The service data were not analyzed for concerned 
clients because they were likely to have had very different service use patterns than substance users 
themselves. Another 74% (ie, out of the 15% dropped for non-linkage, or about 11% of the total 
sample) were from the first month of the cohort year (either July 1993 or July 1996), presumably 
representing episodes already under way when services began to be counted. The final numbers of 
fixed-length episodes were N = 18,490 for FY 1994 and N = 24,743 for FY 1997. Sample sizes for 
the variable-length episodes were N = 22,193 for the FY 1994 cohort and N = 29,686 for the FY 
1997 cohort. 
Dependent variables 
The aggregate s rvice measures examined in the study were inpatient hospital days, inpatient detox 
days, residential detox days, residential non-detox days, regular outpatient services (m asured in 
minutes), methadone maintenance visits, and assessment services (also measured in minutes). These 
measures were constructed using information from several fields on the service records (form type, 
service type, nvironment), following standard Center for Substance Abuse Tr atment definitions. 
The use, but not the level, of intensive outpatient services also was examined. Because patients in 
the study did not use outpatient detox services, they were not studied. In addition to the measures 
mentioned above, total individual counseling minutes and total group counseling minutes were 
examined. These variables aggregated counseling minutes received uring all of the patient's inpatient 
stays and outpatient visits. 
As described above, the dependent variables were defined as the aggregate sum over the entire 
12-month period beginning with the first service for the fixed-length episodes, or over the contiguous 
months of service use for the variable-length episodes. For the variable-length episodes, the number 
of months in the episode and service use per episode-month also were examined, the latter by taking 
each of the dependent variables described above and dividing by the number of months in the episode. 
Independent variables 
Because the study questions focused on the impact of managed care on substance abuse treatment 
patterns, the regressor of primary interest was an indicator equal to 0 if the observation was from 
FY 1994 (the pre-IMSACP period) and 1 if it was from FY 1997 (following the introduction of 
IMSACP). Multiple regression analysis was used to adjust for differences in the characteristics 
of the two patient populations (the FY 1994 versus FY 1997 cohorts) that might confound the 
comparison of their treatment patterns. Regressors included sex, race (black, Asian American, Native 
American/Alaskan Native, other race versus white), Hispanic ethnicity, marital status (married or 
cohabiting, separated/divorced/widowed versus never married), education (less than high school, 
more than high school versus high school), primary source of support (government transfer program, 
wages or salary, family or friends, other income versus none), living situation (lived in an institution, 
lived with other household members, homeless versus lived alone), urbanicity (urban versus rural 
county), referral type (health care provider, civil commitment, other civil or criminal justice, other 
referral versus self-referral; a separate indicator for missing referral source also was included), 
whether employed at admission, whether pregnant, whether had psychiatric problem, frequency of 
use in month prior to admission (estimated number of times each drug was used, added up across all 
drugs used), age at admission, age at first use, number of arrests in the 12 months prior to admission, 
and number of previous admissions to ubstance abuse treatment in the past 10 years. 
A set of dichotomous indicators for each type of substance abused (alcohol, cocaine/crack, mari- 
juana/hashish, methamphetamines, other illicit substances) was included in the model. Because these 
indicators are not mutually exclusive, the effects of multiple drugs are additive. To account for the 
fact that he marginal effect of using drug X may be higher or lower if somebody isalready using drug 
Y, a dichotomous indicator for whether the patient had multiple addictions (1 = yes, 0 = no) also 
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was included in the model. Finally, the regressions controlled for whether the patient was already 
receiving services at the beginning of FY 1994 or FY 1997, in case the exclusion of persons with 
missing admissions data failed to eliminate all the ongoing episodes. 
Statistical analysis 
Descriptive statistics on patient sociodemographic and clinical characteristics and service use pat- 
terns were calculated separately for the FY 1994 and FY 1997 cohorts, using g 2 and Wilcoxon tests 
to test for differences. "Two-part" regression models then were estimated to examine 
differences in service use between the FY 1994 and FY 1997 cohorts after adjusting for the pop- 
ulation characteristics de cribed above. Negative binomial models were used to model months in 
treatment for the sensitivity analyses using the variable-length episodes. The main set of analyses 
pooled all patients who received treatment resulting from their own substance abuse, but the data 
were then reanalyzed separately for special at-risk ubgroups of the substance-abusing population, 
including women, children, and homeless persons. 
The standard errors for all regression analyses were adjusted for provider-level c ustering using 
the Generalized Estimating Equations (GEE) approach. 18,w Essentially, GEE is a nonparametric 
adjustment of the variance-covariance matrix to account for the fact that observations on patients 
treated by the same provider are more closely correlated than observations on patients treated by 
different providers. In the absence of such an adjustment, the standard errors typically would be 
underestimated (and hence statistical significance overstated). 
Multipart models were developed as part of the RAND Health Insurance Experiment study, 2° to 
account for the unusual distribution of most cost and utilization outcomes. Typically these measures 
have large numbers of zero values (ie, most patients do not receive any services within a given 
category), but among persons with non-zero values (the users of services), the conditional distribution 
of service use is highly skewed, with a few patients accounting for a disproportionate amount of total 
use. These features characterized the Iowa substance abuse service data as well, so a two-part model 
of the form E (Y) = pr (Y > 0) • E (Y I Y > 0) was used, where Y represented a particular service 
use measure (eg, number of inpatient days). The first part of the two-part model was estimated as a 
multiple logistic regression of the probability that he patient used any service within that category (eg, 
had any inpatient days). The second part of the two-part model was estimated as a linear regression 
of the level of use among the subset of patients who used the service (eg, the number of inpatient 
days among persons who were admitted to the hospital). Due to the skewed distributions of the 
conditional use measures, log transformations of the dependent variable were used. To retransform 
the parameter stimates to calculate ffects on utilization measured on the original (not log) scale, 
the so-called "smearing" algorithm developed for the Health Insurance Experiment was used, with 
modifications to allow for heteroskedasticity. 21'22 
The formula for the predicted value of the outcome for person j was E (Yj) = [eXjS/(1 + eXj~)] • 
SeXj c~, where Xj is a vector of regressor values for person j,/3 is the vector of coefficient estimates 
from the logistic regression, a is the vector of coefficient estimates from the linear regression, and S 
is the smear factor, defined as the mean of the exponentiated residuals among the relevant subgroup 
(FY 1994 versus FY 1997 cohort). (The purpose of the smear factor is to normalize the predictions 
so that their average reflects the arithmetic mean;  eXj c~ by itself reflects the geometric mean, which 
is approximately the median.) 
Based on the coefficient estimates from the two regressions, three values were then calculated: 
(1) the difference in the predicted probability of use for the FY 1997 versus FY 1994 cohort, (2) the 
difference in the predicted conditional level of use, and (3) the difference in the predicted uncondi- 
tional evel of use. For example, to calculate the "predictive margins" for overall (unconditional) use 
of services, the smear factor was first calculated based only on the observations from the FY 1997 
cohort. The value of the cohort indicator (FY 1997 versus FY 1994) was set to equal 1 for all patients, 
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holding all other regressors at their original values, and the predicted value of the outcome for each 
observation was calculated. The smear factor was then calculated based only on the observations 
from the FY 1994 cohort, the cohort indicator was reset o equal 0 (representing FY 1994), again 
keeping all other regressors at their original values, and the predicted value of the outcome was 
recalculated. Finally, the average of the differences between the two predictions was taken across the 
entire sample. Using 1,000 replicate samples, the investigators derived 99% empirical confidence 
intervals for these differences with standard bootstrapping methods with replacement. 23 
Resu l ts  
Changes in population characteristics over time 
Table 1 presents descriptive information on the sociodemographic characteristics of the patients in 
the FY 1994 versus FY 1997 cohorts. Although all the differences were highly significant statistically, 
this was due to the large sample size and high degree of precision, since the magnitude of the difference 
Tab le  1 
Changes in patient sociodemographic characteristics before and after introduction of managed care 
FY 1994 cohort FY 1997 cohort 
(N = 18,490) (N = 24,743) 
% % 
Female (n = 0 missing) 
Race (n = 3 missing) 
White 
Black 
American Indian or Alaskan Native 
Asian 
Other race 
Hispanic (n = 2 missing) 
Marital status (n = 2 missing) 
Never married 
Married or cohabiting 
Separated, ivorced, or widowed 
Education (n = 1 missing) 
Highest completed grade less than 12 
Highest completed grade equal to 12 
Highest completed grade greater than 12 
Primary source of support (n = 3 missing) 
Government transfer program 
Wages or salary 
Family and friends 
Other income 
None 
Living situation (n = 2 missing) 
Institutionalized 
Lives alone 
Lives with household member(s) 
Homeless 
Lives in urban county (n = 0 missing) 
18 20 
91 88 
6 8 
1 2 
<1 <1 
1 3 
3 4 
50 53 
28 26 
21 20 
28 32 
48 47 
24 21 
5 4 
64 59 
19 21 
3 4 
8 11 
5 3 
17 16 
77 80 
<1 1 
67 70 
Note: Statistics calculated based on non-missing data only. All differences were significant at p < .001. 
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Table  2 
Changes in patient clinical characteristics before and after introduction of managed care 
FY 1994 cohort FY 1997 cohort 
(N : 18,490) (N : 24,743) 
% % 
Referral type (n = 1,075 missing) 
Self-referred 
Health care provider 
Other civil or criminal justice 
Civil commitment 
Other 
Employed at admission (n = 2 missing) 
Pregnant (n = 0 missing) 
Psychiatric/drug problem (n = 1 missing) 
Multiple addictions (n = 1 missing) 
Any alcohol abuse 
Any use of cocaine/crack 
Any use of marijuana/hashish 
Any use of methamphetamines 
Any use of other illicit substances 
19 18 
8 8 
68 69 
1 2 
4 4 
67 63 
<1 <1 
10 16 
26 32 
93 87 
13 13 
35 45 
5 18 
7 7 
Mean (SD) Mean (SD) 
Frequency of use in past month of all 
substances combined 
Age at admission 
Age at first use (n = 0 missing) 
Arrests in past 12 months (n = 4 missing) 
Number of previous admissions in past 
10 years (n = 2 missing) 
15.88 (36.72) 22.31 (47.97) 
30.00 (10.66) 29.85 (10.98) 
15.78 (3.99) 15.71 (4.36) 
0.99 (0.95) 1.08 (1.12) 
0.62 (1.09) 0.71 (1.18) 
SD, standard deviation. 
Note: Statistics calculated based on non-missing data only. All differences significant at p < .001 except referral 
type (p < .01), any use of other illicit substances (p < .01), any use of cocaine/crack (p < .02), and age at 
admission (p < .02). 
was generally trivial. Relative to the FY 1994 cohort, patients in the FY 1997 cohort were just slightly 
more likely to be female, nonwhite, urban, never married, without a source of income or family and 
friends as the source of income, less than a high school education, and live with a household member. 
Table 2 provides descriptive statistics for the clinical characteristics of the patients at admission. 
Patients in the FY 1997 cohort were significantly less likely to have been employed at admission, more 
likely to have had a psychiatric problem and multiple addictions, less likely to have abused alcohol, 
and much more likely to have abused marijuana/hashish and methamphetamines. Frequency of use 
at admission was substantially higher in the FY 1997 cohort, and the number of previous admissions 
to substance abuse treatment during the past 10 years was slightly higher. 
Unadjusted changes in substance abuse treatment patterns over time 
Table 3 tests differences between FY 1994 and FY 1997 in unadjusted service use patterns. 
Due again to large sample sizes, all the differences were highly significant statistically except for 
one. Before adjusting for changes in the sociodemographic and clinical characteristics, episodes 
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Tab le  3 
Changes in unadjusted substance abuse service use before and after introduction of managed care 
FY 1994 cohort FY 1997 cohort 
(N = 18,490) (N = 24,743) 
Inpatient hospital days 
Percentage with any use 
Mean days, users only 
Mean days, everybody 
Inpatient detox days 
Percentage with any use 
Mean days, users only 
Mean days, everybody 
Residential detox days 
Percentage with any use 
Mean days, users only 
Mean days, everybody 
Residential non-detox days 
Percentage with any use 
Mean days, users only 
Mean days, everybody 
Intensive outpatient days 
Percentage with any use 
Methadone maintenance visits 
Percentage with any use 
Mean visits, users only 
Mean visits, everybody 
Regular outpatient minutes 
Percentage with any use 
Mean visits, users only 
Mean visits, everybody 
Assessment minutes 
Percentage with any use 
Mean minutes, users only 
Mean minutes, everybody 
Individual counseling minutes 
Percentage with any use 
Mean minutes, users only 
Mean minutes, everybody 
Group counseling minutes 
Percentage with any use 
Mean minutes, users only 
Mean minutes, everybody 
1.29 0.82 
14.94 (SD = 10.36) 9.48 (SD = 7.17) 
0.19 (SD = 2.06) 0.08 (SD = 1.07) 
0.65 1.18 
8.89 (SD = 5.98) 7.19 (SD = 7.81) 
0.06 (SD = 0.86) 0.08 (SD = 1.15) 
1.10 3.44 
4,29 (SD ---- 11.45) 5.65 (SD = 6.60) 
0.05 (SD = 1.28) 0.19 (SD = 1.60) 
12.37 11.08 
42,77 (SD = 46.32) 32.89 (SD = 36,23) 
5,29 (SD = 21.53) 3.64 (SD = 15,87) 
3.42 13.62 
0.41 0.22 
45 (SD = 21) 60 (SD =0) 
< 1 (SD = 3) < 1 (SD = 3) 
54.70 39.64 
906 (SD = 1191) 586 (SD = 685) 
495 (SD = 990) 232 (SD = 518) 
83.35 85.87 
139 (SD = 91) 76 (SD =41) 
116 (SD = 98) 65 (SD = 46) 
48.69 36.11 
375 (SD = 406) 265 (SD = 284) 
182 (SD = 340) 96 (SD ----- 213) 
28.31 17.69 
1084 (SD = 1396) 749 (SD = 776) 
307 (SD = 889) 133 (SD = 434) 
SD, standard deviation. 
Note: All differences were significant at p < .001, with the exception f the difference in mean umbers of 
methadone maintenance visits among users only, which was insignificant. 
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beginning in FY 1997 were associated with fewer inpatient hospital days and residential non-detox 
days than those beginning in FY 1994. The reduction was due to both lower probabilities of use and 
conditional levels of use. In contrast, both the probability and conditional use of residential detox 
days increased over time. The probability of having inpatient detox days also was higher, so even 
though the average number of inpatient detox days among users was lower, the mean days among 
the entire sample was slightly higher in FY 1997 than in FY 1994. The opposite pattern was seen 
with methadone maintenance visits, although its use was extremely rare. 
The probability of receiving intensive outpatient services increased substantially. However, use 
of regular outpatient counseling was substantially reduced, in terms of both the probability of any 
use and the average number of counseling minutes r ceived by users. This was due to reductions in 
both individual and group counseling. The average number of assessment minutes across the entire 
sample also was reduced, despite a small increase in the probability of receipt. 
Adjusted changes in substance abuse treatment patterns over time 
Fixed.length episodes 
Table 4 shows the results from the two-part regression models based on the fixed-length episodes. 
The second column gives the relative risks for the probability of any use of the service, that is, 
Table 4 
Estimated impact of post-managed care period versus pre-managed care period on substance abuse 
service use: Fixed-length episodes 
Percentage change in Absolute change in 
Relative risk conditional expected use unconditional 
of any use (%) expected use 
Inpatient hospital days 
Inpatient detox days 
Residential detox days 
Residential non-detox days 
Intensive outpatient days 
Methadone maintenance visits 
Regular outpatient minutes 
Assessment minutes 
Individual counseling minutes 
Group counseling minutes 
0.44 --66 --0.27 
(0.34, 0.55) (--73, --55) (--0.36, --0.20) 
1.60 --25 0.01 
(1.20, 2.18) (--45, --6) (-0.02, 0.04) 
2.85 17 0.11 
(2.30, 3.76) ( -21,  84) (0.08, 0.15) 
0.67 --24 --2.63 
(0.62, 0.74) (--30, -- 18) (--3.07, -2.14) 
3.64 
(3.31, 4.09) 
0.69 61 0.04 
(0.39, 1.36) (7, 159) (-0.05, 0.21) 
0.72 --35 --262 
(0.69, 0.74) (--37, --32) (--282, --243) 
1.06 --45 --49 
(1.04, 1.07) (--46, --44) (--51, --47) 
0.73 --29 --87 
(0.71, 0.75) (--32, --26) (--94, --80) 
0.63 -- 30 -- 169 
(0.60, 0.65) (--34, -- 26) (-- 187, -- 151) 
Notes: N = 18,490 for the FY 1994 cohort and N = 24,743 for the FY 1997 cohort. The two-part models adjusted 
for the sociodemographic and clinical characteristics shown in Tables 1 and 2. Boot trapped 99% confidence 
intervals are shown in parentheses. Bold denotes significance at u ---- .01. 
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the mean predicted probability that an episode would include the given service if it were from FY 
1997, divided by the mean predicted probability if the episode were from FY 1994 instead. The 
third column gives the percentage increase or decrease in the amount of the service used among the 
subsample of episodes that included any use of the service. The last column gives the level change in 
the expected amount of the service used among the entire sample. The results were very consistent 
with the unadjusted ifferences seen in Table 3, except hat after regression adjustment there were 
no longer significant differences in the probability of any methadone use, the expected number of 
residential detox days among users of residential detox, and the expected number of inpatient detox 
days or methadone maintenance visits among the entire sample. 
Variable-length episodes 
Table 5 shows the regression results from sensitivity analyses using the variable-length episodes. 
Months in treatment dropped by -0.36 months, which is approximately a 14% decline (the mean 
number of months in treatment for the FY 1994 cohort was 2.51, with a standard eviation of 2.45). 
However, this result should be viewed with caution, as the dates of service within each month could not 
be determined from the monthly service records, so the exact duration of treatment also could not be 
determined. The variable-length episode results for the relative risks of use and changes in conditional 
and unconditional use for services received during the entire episode looked very similar to those 
from the fixed-length episodes, except hat the change in the conditional number of inpatient detox 
days lost significance. Additional results howed that the intensity of services (number of days, visits, 
or minutes per episode-month) followed the same patterns as service use during the entire episode. 
Subgroup analyses 
The impact of behavioral health managed care initiatives on vulnerable treatment population 
subgroups uch as women, children, and the homeless is of particular interest o state and federal 
policy makers. To this end, separate analyses were conducted for women, children (defined as 
individuals who were less than or equal to 18 years of age), and homeless individuals contained in 
the constructed FY 1994 and FY 1997 cohorts. Although the smaller sample sizes reduced statistical 
significance levels in many cases and often prevented the estimation of a regression model, the 
conclusions remained substantially the same (tables available from the corresponding author upon 
request). 
Women looked very similar to the sample as a whole. In contrast, children showed some differences, 
demonstrating increases, rather than declines, in the probability of inpatient hospital days and the 
average number of hospital days among the entire sample. They also experienced declines in the 
average number of residential detox days among users and among the entire sample. Unfortunately, 
sample sizes were too small to estimate regression models for some of the dependent variables. As 
a result, it could not be determined whether the adjusted ifferences would show the same patterns 
as the unadjusted ata. 
The number of homeless individuals admitted for service and reflected in the SARS database 
increased steadily over the 5-year course of this study. Based on self-report, here were 235 unique 
homeless individuals admitted in FY 1994 and 840 individuals in FY 1998, an increase of 257%. 
While the absolute number of individuals is relatively small, the homeless represent both the most 
disadvantaged treatment subgroup and the one usually utilizing a disproportionate share of resources. 
This combination makes them a prime target for service reductions to decrease costs. Based on the 
analysis conducted, the service patterns among homeless persons looked very much like those among 
the entire sample, with the same directions of the effects, except hat the tiny sample sizes for the 
homeless population prevented most of the effects from achieving statistical significance. Again, 
very few of the outcome measures could be estimated using regression analysis. 
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Table 5 
Estimated impact of post-managed care period versus pre-managed care on substance abuse 
service use: Variable-length episodes 
Relative risk 
of any use 
Percentage change in 
conditional expected 
use (%) 
Absolute change in 
unconditional 
expected use 
Months in treatment 
Inpatient hospital days 
Entire episode 
Per episode-month 
Inpatient detox days 
Entire episode 
Per episode-month 
Residential detox days 
Entire episode 
Per episode-month 
Residential non-detox days 
Entire episode 
Per episode-month 
Intensive outpatient days 
0.45 
(0.35, 0.57) 
1.68 
(1.27, 2.27) 
3.57 
(2.85, 4.53) 
0.66 
(0.61, 0.72) 
3.92 
(3.50, 4.45) 
Methadone maintenance visits 
Entire episode 0.57 
Per episode-month (0.31, 0.95) 
Regular outpatient minutes 
Entire episode 0.74 
Per episode-month (0.72, 0.76) 
Assessment minutes 
Entire episode 1.09 
Per episode-month (1.08, 1.10) 
Individual counseling minutes 
Entire episode 0.76 
Per episode-month (0.74, 0.79) 
Group counseling minutes 
Entire episode 0.62 
Per episode-month (0.59, 0.65) 
--68 (--76, --57) 
--59 (--71, --39) 
-11 (-35, 16) 
-6  (-34, 25) 
-10  (-38, 70) 
52 (13, 137) 
--27 (--33, --21) 
--18 (--23, --14) 
--0.36 (--0.42, --0.31) 
--0.25 (--0.35, --0.19) 
--0.11 (--0.16, --0.08) 
0.02 (-0.001, 0.04) 
0.02 (-0.000, 0.03) 
0.07 (0.05, 0.10) 
0.07 (0.05, 0.08) 
--2.32 (--2.77, -- 1.92) 
--0.56 (--0.67, --0.47) 
72 (22, 170) 0.03 (--0.05, 0.12) 
175 (62, 378) 0.02 (--0.01, 0.05) 
--38 (--40, --35) --223 (--241, --206) 
--44 (--47, --41) --90 (--98, --82) 
--46 (--47, --45) --39 (--41, --38) 
--36 (--37, --35) --18 (--19, --17) 
--30 (--33, --27) --65 (--71, --59) 
--27 (--30, --25) --15 (--16,--14) 
--33 (--37, --28) --155 (--171, --140) 
--41 (--45, --37) --78 (--86,--70) 
Notes: N =22,193 for the FY 1994 cohort and N =29,686 for the FY 1997 cohort. The negative binomial 
and two-part models adjusted for the sociodemographic and clinical characteristics shown in Tables 1 and 2. 
Bootstrapped 99% confidence intervals are shown in parentheses. Bold denotes significance at ot = .01. 
Discussion 
In summary, several general time trends in the delivery of substance abuse services to non-Medicaid 
clients were observed. There was some evidence that patient case mix may have changed over time, 
being increasingly composed of patients with a higher burden of illness. The pattern that severity 
at admission may have increased concurrently with the introduction of managed care is at least 
consistent with the hypothesis that indigent Iowa residents experienced reduced access to substance 
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abuse services under managed care, so that, on the margin, those g tting into treatment were sicker. 
On the other hand, the income eligibility criteria for receiving state-funded non-Medicaid services 
dropped from 400% of the federal poverty level to 300% between FY 1994 and FY 1997, so some of 
the changes in case mix may have reflected the policy decision to be more restrictive in admissions, 
rather than a managed care effect. 
Despite the evidence that the patient population might be increasing in its burden of illness, in both 
unadjusted and regression-adjusted comparisons, the use of inpatient hospital and residential non- 
detox services declined between FY 1994 and FY 1997, as did outpatient counseling and assessment 
minutes. In contrast, both the probability of intensive outpatient use and the number of residential 
detox days increased. Regression adjustment for the changing case mix of the patient population did 
not have a large effect on the results, probably because population characteristics did not change 
that much over this period of time. Findings were similar among subsamples of women, children, 
and homeless, with the exception that children experienced increases in the use of inpatient hospital 
days and declines in the use of residential detox days. 
These findings are consistent with the results of previous studies suggesting that while access 
to substance abuse treatment remains constant or even increases under managed care, 24'25 use of  
inpatient services declines and is not necessarily offset by increases in outpatient care. 26-28 
The results presented here should be interpreted with caution, due to several limitations of the 
data analysis. First, and perhaps most important, data were not available for a comparison group of 
patients who were not affected by the introduction of IMSACP, so it was not possible to tell whether 
the changes in treatment patterns between FY 1994 and FY 1997 were attributable tomanaged care 
or simply represented confounding secular time trends. A related problem was that the SARS data 
system changed slightly in FY 1996 (at the same time managed care was being introduced), so some 
of the service variables had to be cross-walked across years and may not have always been perfectly 
matched in their usage. 
Second, the database was imperfect. The Iowa state substance abuse treatment files had the advan- 
tage of being relatively rich in demographic and clinical data. Their limitations were that they did not 
include outcome measures; information on payment source was not always reliable; the discharge 
files were frequently incomplete because of treatment dropouts and the absence of incentives to 
submit data, so could not be used for the study; and service use was ummarized on a monthly basis, 
hindering amore clinically meaningful definition of episodes. 
Third, the SARS database contained episodes of some patients whose substance abuse treatment 
was not paid by the IDPH, so were not subject to managed care. To explore this issue, sensitivity 
analysis was performed restricting the sample to the 18,841 patients whose admissions record listed 
IDPH as the source of payment. In bivariate comparisons, imilar results were found, except hat 
the effect of year on rare events (inpatient hospital days and inpatient detox days) was no longer 
significant. Multiple regression analyses also revealed very similar results for the outcomes with 
sufficient sample sizes to estimate the models (ie, all outcomes except inpatient hospital, inpatient 
detox, and methadone maintenance). 
Fourth, these results may not generalize to other states. More than half of Iowa's approximately 
3 million residents live outside metropolitan areas, and Iowa has a small minority population, with less 
than 6% nonwhite. Iowa looks better than the national average according to various measures of health 
status (eg, infant mortality, low-birth-weight infants, and infection with human immunodeficiency 
virus) and criminal activity (eg, known crimes, arrests, and prison population). States with more 
urban, less healthy, or more diverse patient populations might have responded differently to a similar 
managed care initiative. 
Last, the database did not contain any outcome measures. Readers should be cautioned against 
interpreting increases or decreases in service use as better or worse care. Extra services may represent 
either higher-quality care or unnecessary services, since services used do not necessarily correspond 
to the recommended treatment regimen. Conversely, fewer services may imply reductions in quality, 
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but may simply reflect greater efficiency, although past research 29 has found mixed evidence on 
the relationship between managed care and technical efficiency in the provision of substance abuse 
treatment. To allow appropriate interpretation f the data, information about patient outcomes uch 
as service completion, discharge status, recidivism, functioning, employment s atus, and criminal 
activity should be collected. 
Implications for Behavioral Health Services 
In contrast to the findings based on early implementation data, the analyses of the SARS data 
reported here suggest that changes in the provision of services to non-Medicaid service recipients 
did occur in conjunction with the implementation f IMSACP, and that these changes were generally 
consistent across treatment subgroups. Consistent with the usual hypotheses and empirical evidence 
regarding the impact of managed care, there was a movement away from high-cost inpatient care to 
lower-cost care. Decreases in service use were observed in four of the seven treatment modalities. 
Decreases also were observed in more general measures of service use (ie, individual counseling, 
group counseling, and time spent in assessment). However, without knowing whether the reductions 
in service use were associated with better, worse, or similar treatment outcomes, it is impossible to 
know whether these changes in service use should be interpreted as improved provider efficiency in 
treating clients, or simply cost containment and profit maximization atthe expense of client well- 
being. Additional study is required to assess the impact of substance abuse service decreases on 
client outcome. 
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